Functional studies have demonstrated that the SP-like family of TFs regulates various genes responsible for cancer-related cellular mechanisms; SP1, SP3, and SP4 are also non-oncogene addiction (NOA) genes and thus are important drug targets [33]. The gene discussed is SP3; the disease is cancer.